Tags: Drug.
Talizumab (TNX-901) is a humanized monoclonal antibody that was under development by Tanox in Houston Texas as a new-concept therapeutic for allergic diseases. The unique anti-IgE antibody was designed to target immunoglobulin E (IgE) and IgE-expressing B lymphocytes specifically without binding to IgE already bound by the high affinity IgE receptors on mast cells and basophils.